{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:21:33Z","timestamp":1762309293267,"version":"build-2065373602"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,14]],"date-time":"2025-08-14T00:00:00Z","timestamp":1755129600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurolog\u00eda (English Edition)"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.nrleng.2025.08.002","type":"journal-article","created":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:15:13Z","timestamp":1762308913000},"page":"915-923","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluation of autonomic dysfunction in hereditary transthyretin amyloidosis"],"prefix":"10.1016","volume":"40","author":[{"given":"F.","family":"Mart\u00ednez-Valle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Casasnovas-Pons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Romero-Acebal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Gal\u00e1n-D\u00e1vila","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.nrleng.2025.08.002_bib0240","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jns.12153","article-title":"Red-flag symptom clusters in transthyretin familial amyloid polyneuropathy","volume":"21","author":"Concei\u00e7\u00e3o","year":"2016","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0245","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1055\/s-0039-1688994","article-title":"Neuropathy associated with systemic amyloidosis","volume":"39","author":"Kaku","year":"2019","journal-title":"Semin Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0250","doi-asserted-by":"crossref","first-page":"625","DOI":"10.3109\/07853890.2015.1068949","article-title":"Evolving landscape in the management of transthyretin amyloidosis","volume":"47","author":"Hawkins","year":"2015","journal-title":"Ann Med"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0255","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10286-019-00630-y","article-title":"Characteristics and natural history of autonomic involvement in hereditary ATTR amyloidosis: a systematic review","volume":"29","author":"Gonzalez-Duarte","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0260","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s10286-018-0514-2","article-title":"Autonomic involvement in hereditary transthyretin amyloidosis (hATTR amyloidosis)","volume":"29","author":"Gonzalez-Duarte","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0265","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1007\/s00415-019-09602-8","article-title":"Analysis of autonomic outcomes in APOLLO, a phase III trial of the RNAi therapeutic patisiran in patients with hereditary transthyretin-mediated amyloidosis","volume":"267","author":"Gonz\u00e1lez-Duarte","year":"2020","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0270","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1750-1172-8-31","article-title":"Guideline of transthyretin-related hereditary amyloidosis for clinicians","volume":"8","author":"Ando","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0275","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/s40120-020-00183-7","article-title":"Impact of non-cardiac clinicopathologic characteristics on survival in transthyretin amyloid polyneuropathy","volume":"9","author":"Gonz\u00e1lez-Duarte","year":"2020","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0280","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/CND.0000000000000252","article-title":"Phenotypes of late-onset transthyretin amyloid neuropathy: a diagnostic challenge","volume":"21","author":"\u017divkovi\u0107","year":"2019","journal-title":"J Clin Neuromuscul Dis"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0285","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1212\/WNL.58.7.1001","article-title":"Familial transthyretin-type amyloid polyneuropathy in Japan: clinical and genetic heterogeneity","volume":"58","author":"Ikeda","year":"2002","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0290","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1080\/13506129.2019.1582023","article-title":"Cardiac and peripheral vasomotor autonomic functions in hereditary transthyretin amyloidosis with non-Val30Met mutation","volume":"26","author":"Koike","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0295","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1750-1172-9-61","article-title":"THAOS: gastrointestinal manifestations of transthyretin amyloidosis \u2013 common complications of a rare disease","volume":"9","author":"Wixner","year":"2014","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0300","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0305","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Inotersen treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0310","doi-asserted-by":"crossref","first-page":"2802","DOI":"10.1007\/s00415-013-7051-7","article-title":"Long-term effects of tafamidis for the treatment of transthyretin familial amyloid polyneuropathy","volume":"260","author":"Coelho","year":"2013","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0315","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1007\/s40292-016-0162-3","article-title":"Autonomic dysfunction: how to identify and when to treat?","volume":"23","author":"Saladini","year":"2016","journal-title":"High Blood Press Cardiovasc Prev"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0320","doi-asserted-by":"crossref","first-page":"1442","DOI":"10.1016\/j.jcmg.2016.08.003","article-title":"Cardiac dysautonomia and survival in hereditary transthyretin amyloidosis","volume":"9","author":"Goldstein","year":"2016","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0325","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1016\/S1474-4422(11)70246-0","article-title":"Familial amyloid polyneuropathy","volume":"10","author":"Plant\u00e9-Bordeneuve","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0330","doi-asserted-by":"crossref","first-page":"102590","DOI":"10.1016\/j.autneu.2019.102590","article-title":"Blood pressure and orthostatic hypotension as measures of autonomic dysfunction in patients from the transthyretin amyloidosis outcomes survey (THAOS)","volume":"222","author":"Gonz\u00e1lez-Duarte","year":"2019","journal-title":"Auton Neurosci Basic Clin"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0335","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1007\/s10286-019-00624-w","article-title":"Strategies to improve the quality of life in patients with hereditary transthyretin amyloidosis (hATTR) and autonomic neuropathy","volume":"29","author":"Gendre","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0340","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s10286-019-00623-x","article-title":"Orthostatic hypotension in hereditary transthyretin amyloidosis: epidemiology, diagnosis and management","volume":"29","author":"Palma","year":"2019","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0345","doi-asserted-by":"crossref","first-page":"116424","DOI":"10.1016\/j.jns.2019.116424","article-title":"Development of measures of polyneuropathy impairment in hATTR amyloidosis: from NIS to mNIS+7","volume":"405","author":"Dyck","year":"2019","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0350","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1186\/s12883-017-0948-5","article-title":"Trial design and rationale for APOLLO, a phase 3, placebo-controlled study of patisiran in patients with hereditary ATTR amyloidosis with polyneuropathy","volume":"17","author":"Adams","year":"2017","journal-title":"BMC Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0355","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/mus.25563","article-title":"Assessing mNIS+7 Ionis and international neurologist proficiency in a familial amyloidotic polyneuropathy trial","volume":"56","author":"Dyck","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0360","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s10286-005-0246-y","article-title":"What is the minimum duration of head-up tilt necessary to detect orthostatic hypotension?","volume":"15","author":"Gehrking","year":"2005","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0365","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1002\/ana.24438","article-title":"Sudomotor innervation in transthyretin amyloid neuropathy: pathology and functional correlates","volume":"78","author":"Chao","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0370","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s10286-008-0506-8","article-title":"Sweat testing to evaluate autonomic function","volume":"19","author":"Illigens","year":"2009","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0375","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1007\/s11892-013-0392-x","article-title":"Neurovascular function and sudorimetry in health and disease","volume":"13","author":"Vinik","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0380","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1016\/j.clinph.2016.02.013","article-title":"The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy","volume":"127","author":"Castro","year":"2016","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0385","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1001\/jamaophthalmol.2016.1889","article-title":"Potential role of in vivo confocal microscopy for imaging corneal nerves in transthyretin familial amyloid polyneuropathy","volume":"134","author":"Rousseau","year":"2016","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0390","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1007\/s00415-007-0617-5","article-title":"A brief compound test for assessment of autonomic and sensory-motor dysfunction in familial amyloid polyneuropathy","volume":"254","author":"Denier","year":"2007","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0395","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1212\/WNL.0b013e3182120147","article-title":"Assessing autonomic dysfunction in early diabetic neuropathy: the survey of autonomic symptoms","volume":"76","author":"Zilliox","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0400","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/jns5.12059","article-title":"Norfolk QOL-DN: validation of a patient reported outcome measure in transthyretin familial amyloid polyneuropathy","volume":"19","author":"Vinik","year":"2014","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0405","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.2169\/internalmedicine.1113-18","article-title":"Widespread cardiac and vasomotor autonomic dysfunction in non-val30met hereditary transthyretin amyloidosis","volume":"57","author":"Koike","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0410","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/S0735-1097(96)00438-X","article-title":"Iodine-123 metaiodobenzylguanidine scintigraphic assessment of myocardial sympathetic innervation in patients with familial amyloid polyneuropathy","volume":"29","author":"Tanaka","year":"1997","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0415","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1161\/CIRCIMAGING.112.000367","article-title":"Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy","volume":"6","author":"Coutinho","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0420","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/mus.25257","article-title":"Clinical measures in transthyretin familial amyloid polyneuropathy","volume":"55","author":"Coelho","year":"2017","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0425","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.jns.2014.06.041","article-title":"Retrospective study of a TTR FAP cohort to modify NIS+7 for therapeutic trials","volume":"344","author":"Suanprasert","year":"2014","journal-title":"J Neurol Sci"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0430","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/WNP.0000000000000452","article-title":"Utility of time and frequency domain parameters of heart rate variability in the context of autonomic disorders characterized by orthostatic dysfunction","volume":"35","author":"Baker","year":"2018","journal-title":"J Clin Neurophysiol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0435","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/B978-0-444-52902-2.00007-2","article-title":"Testing the autonomic nervous system","volume":"115","author":"Freeman","year":"2013","journal-title":"Handb Clin Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0440","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1007\/s00415-019-09688-0","article-title":"Expert consensus recommendations to improve diagnosis of ATTR amyloidosis with polyneuropathy","volume":"268","author":"Adams","year":"2021","journal-title":"J Neurol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0445","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3389\/fnagi.2016.00199","article-title":"Electrochemical skin conductance correlates with skin nerve fiber density","volume":"8","author":"Novak","year":"2016","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0450","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.clinph.2018.04.608","article-title":"Assessing sudomotor impairment in patients with peripheral neuropathy: comparison between electrochemical skin conductance and skin biopsy","volume":"129","author":"Duchesne","year":"2018","journal-title":"Clin Neurophysiol"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0455","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1080\/13506129.2019.1582494","article-title":"Correlation between Sudoscan and COMPASS 31: assessment of autonomic dysfunction on hATTR V30M patients","volume":"26","author":"Concei\u00e7\u00e3o","year":"2019","journal-title":"Amyloid"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0460","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s10286-017-0425-7","article-title":"The autonomic medical history","volume":"27","author":"Goldstein","year":"2017","journal-title":"Clin Auton Res"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0465","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s40120-014-0023-8","article-title":"Post hoc analysis of nutritional status in patients with transthyretin familial amyloid polyneuropathy: impact of tafamidis","volume":"3","author":"Suhr","year":"2014","journal-title":"Neurol Ther"},{"key":"10.1016\/j.nrleng.2025.08.002_bib0470","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1056\/NEJMoa1805689","article-title":"Tafamidis treatment for patients with transthyretin amyloid cardiomyopathy","volume":"379","author":"Maurer","year":"2018","journal-title":"N Engl J Med"}],"container-title":["Neurolog\u00eda (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000793?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173580825000793?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T02:16:49Z","timestamp":1762309009000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173580825000793"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2173580825000793"],"URL":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.08.002","relation":{},"ISSN":["2173-5808"],"issn-type":[{"value":"2173-5808","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of autonomic dysfunction in hereditary transthyretin amyloidosis","name":"articletitle","label":"Article Title"},{"value":"Neurolog\u00eda (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nrleng.2025.08.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Sociedad Espa\u00f1ola de Neurolog\u00eda. Published by Elsevier Espa\u00f1a, S.L.U.","name":"copyright","label":"Copyright"}]}}